Eli Lilly Raises Full-Year Forecast After Beating Profit and Sales Expectations
The American pharmaceutical giant Eli Lilly, Danish Novo's main competitor, is beating profit expectations and raising its forecast for the year.
BusinessTop news
Novo cuts Wegovy price by 20% in Sweden as subsidy bid continues
Pharmaceutical giant Novo is cutting the price of its weight loss drug Wegovy by 20 percent on the Swedish market. At the same time, the company is working to get the drug subsidized.
Business
Novo Nordisk considers hair loss market as new growth area
Hair loss could become weight-loss giant Novo's new cash cow.
BusinessYou're up to date in Eli Lilly and Company
That's every story in Eli Lilly and Company for now.